About

Translational Research (TR) Company, a division of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), has developed proprietary technology for nasal drug delivery, μco™ System ( “myu-co” system). The system is comprised of two technological elements, powder carrier technology and delivery device technology. In addition to licensing out platform technology and products developed in-house to pharmaceutical companies, SNBL provides support for R&D of drug products applying the group’ s vast experience and capacity for drug development as a contract research organization (CRO) and its state-of-the-art preclinical and clinical study facilities recognized world-wide.